(Q33999444)

30 July 2017

1 reference

title

Treatment of epilepsy in the new millennium (English)

1 reference

30 July 2017

Pellock JM

1

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 August 2000

1 reference

30 July 2017

1 reference

30 July 2017

volume

20

1 reference

30 July 2017

issue

8 Pt 2

1 reference

30 July 2017

page(s)

129S-138S

1 reference

Proposal for revised classification of epilepsies and epileptic syndromes. Commission on Classification and Terminology of the International League Against Epilepsy

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.12.129S.35252

Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic-clonic seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.12.129S.35252

A comparison of valproate with carbamazepine for the treatment of complex partial seizures and secondarily generalized tonic-clonic seizures in adults. The Department of Veterans Affairs Epilepsy Cooperative Study No. 264 Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.12.129S.35252

Phenobarbitone, phenytoin, carbamazepine, or sodium valproate for newly diagnosed adult epilepsy: a randomised comparative monotherapy trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.12.129S.35252

Tonic-clonic seizures: a systematic review of antiepilepsy drug efficacy and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.12.129S.35252

Mechanism of action of the anticonvulsant felbamate: opposing effects on N-methyl-D-aspartate and gamma-aminobutyric acidA receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.12.129S.35252

Utilization of new antiepileptic drugs in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.12.129S.35252

Evaluation of case reports of aplastic anemia among patients treated with felbamate

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.12.129S.35252

A summary of mechanistic hypotheses of gabapentin pharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.12.129S.35252

New antiepileptic drugs in children: present and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.12.129S.35252

High dose gabapentin in refractory partial epilepsy: clinical observations in 50 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.12.129S.35252

Gabapentin in naive childhood absence epilepsy: results from two double-blind, placebo-controlled, multicenter studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.12.129S.35252

Behavioral side effects of gabapentin in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.12.129S.35252

Gabapentin toxicity in children manifesting as behavioral changes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.12.129S.35252

Lamotrigine for generalized seizures associated with the Lennox-Gastaut syndrome. Lamictal Lennox-Gastaut Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.12.129S.35252

Lamotrigine for the treatment of epilepsy in childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.12.129S.35252

EEG slow waves and memory performance during the intracarotid amobarbital test

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.12.129S.35252

Long-term safety and efficacy of lamotrigine (Lamictal) in paediatric patients with epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.12.129S.35252

Lamotrigine: pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.12.129S.35252

Adjunctive treatment of partial seizures with tiagabine: a placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.12.129S.35252

Tiagabine for complex partial seizures: a randomized, add-on, dose-response trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.12.129S.35252

Effects of tiagabine monotherapy on abilities, adjustment, and mood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.12.129S.35252

Preliminary observations on topiramate in pediatric epilepsies

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.12.129S.35252

Topiramate monotherapy for partial onset seizures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.12.129S.35252

Vigabatrin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in epilepsy and disorders of motor control

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.12.129S.35252

Vigabatrin-associated retinal cone system dysfunction: electroretinogram and ophthalmologic findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.12.129S.35252

Vigabatrin in the management of generalized seizures in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.12.129S.35252

Safety and efficacy of oxcarbazepine: results of randomized, double-blind trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.12.129S.35252

Overview of lamotrigine and the new antiepileptic drugs: the challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.12.129S.35252

Tiagabine pharmacology in profile

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.12.129S.35252

10.1592/PHCO.20.12.129S.35252

21 January 2018

Identifiers

DOI

1 reference

30 July 2017

1 reference